This HTML5 document contains 92 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dbpedia-shhttp://sh.dbpedia.org/resource/
dctermshttp://purl.org/dc/terms/
yago-reshttp://yago-knowledge.org/resource/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n15https://global.dbpedia.org/id/
yagohttp://dbpedia.org/class/yago/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
n20http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#
dbpedia-srhttp://sr.dbpedia.org/resource/
freebasehttp://rdf.freebase.com/ns/
n7http://commons.wikimedia.org/wiki/Special:FilePath/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
dbphttp://dbpedia.org/property/
provhttp://www.w3.org/ns/prov#
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
goldhttp://purl.org/linguistics/gold/
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:MAM-2201
rdf:type
yago:Drug103247620 yago:Abstraction100002137 owl:Thing yago:CausalAgent100007347 dbo:Drug yago:Formula106816935 yago:Matter100020827 yago:Substance100020090 yago:PsychoactiveDrug104017137 dbo:ChemicalSubstance n20:ChemicalObject yago:Communication100033020 yago:PhysicalEntity100001930 yago:MolecularFormula106817173 yago:DesignerDrug103179489 yago:Statement106722453 wikidata:Q8386 yago:Agent114778436 yago:WikicatDesignerDrugs yago:Message106598915 yago:WikicatMolecularFormulas
rdfs:label
MAM-2201
rdfs:comment
MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends. Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries.
foaf:depiction
n7:MAM-2201_structure.png
dcterms:subject
dbc:CB1_receptor_agonists dbc:CB2_receptor_agonists dbc:Naphthoylindoles dbc:Organofluorides dbc:Designer_drugs
dbo:wikiPageID
36392139
dbo:wikiPageRevisionID
1091624626
dbo:wikiPageWikiLink
dbr:Temporary_class_drug dbr:5F-JWH-398 dbc:Naphthoylindoles dbr:Synthetic_cannabis dbc:CB1_receptor_agonists dbc:CB2_receptor_agonists dbr:Research_chemical dbr:Structural_scheduling_of_synthetic_cannabinoids dbr:EAM-2201 dbr:AM-2201 dbr:Cannabinoid_receptor dbr:JWH-122 dbr:THJ-2201 dbr:Agonist dbc:Organofluorides dbr:Schedule_I_Controlled_Substance dbc:Designer_drugs dbr:NM-2201 dbr:RCS-4 dbr:AB-001
owl:sameAs
freebase:m.0k9175y n15:4r9b7 yago-res:MAM-2201 dbpedia-sh:MAM-2201 wikidata:Q6714263 dbpedia-sr:MAM-2201
dbp:wikiPageUsesTemplate
dbt:Cannabinoids dbt:Reflist dbt:Short_description dbt:Fdacite dbt:Use_dmy_dates dbt:Drugbox dbt:Cascite
dbo:thumbnail
n7:MAM-2201_structure.png?width=300
dbp:c
25
dbp:casNumber
1354631
dbp:chemspiderid
28289977
dbp:f
1
dbp:h
24
dbp:iupacName
methanone
dbp:legalDe
Anlage II
dbp:legalUk
Class B
dbp:legalUs
Schedule I
dbp:n
1
dbp:o
1
dbp:pubchem
66570720
dbp:smiles
FCCCCCnc2ccccc2c4Cc3cccc1ccccc13
dbp:stdinchi
1
dbp:stdinchikey
IGBHZHCGWLHBAE-UHFFFAOYSA-N
dbp:unii
P4KP9PRG29
dbp:width
150
dbo:abstract
MAM-2201 (4'-methyl-AM-2201, 5"-fluoro-JWH-122) is a drug that presumably acts as a potent agonist for the cannabinoid receptors. It had never previously been reported in the scientific or patent literature, and was first identified by laboratories in the Netherlands and Germany in June 2011 as an ingredient in synthetic cannabis smoking blends. Like RCS-4 and AB-001, MAM-2201 thus appears to be a novel compound invented by "research chemical" suppliers specifically for grey-market recreational use. Structurally, MAM-2201 is a hybrid of two known cannabinoid compounds JWH-122 and AM-2201, both of which had previously been used as active ingredients in synthetic cannabis blends before being banned in many countries. A study of MAM-2201 in rats showed that it causes neurofunctional disruptions.
dbp:legalCa
Schedule II
dbp:legalNz
Temporary Class
gold:hypernym
dbr:Drug
prov:wasDerivedFrom
wikipedia-en:MAM-2201?oldid=1091624626&ns=0
dbo:wikiPageLength
5836
dbo:casNumber
1354631-24-5
dbo:fdaUniiCode
P4KP9PRG29
dbo:pubchem
66570720
foaf:isPrimaryTopicOf
wikipedia-en:MAM-2201